Patents Assigned to AvroBio, Inc.
  • Publication number: 20220111005
    Abstract: Described herein are methods for treating a subject having or at risk of developing a neurocognitive disorder, such as frontotemporal lobar degeneration or neuronal ceroid lipofuscinosis, by administering cells that contain a transgene encoding a progranulin (PGRN) or a granulin (GRN) or cells that express the PGRN or the GRN to the subject. Also disclosed are compositions comprising cells containing the transgene encoding the PGRN or the GRN.
    Type: Application
    Filed: January 31, 2020
    Publication date: April 14, 2022
    Applicants: AvroBio, Inc., AvroBio, Inc.
    Inventors: Chris MASON, Oliver COOPER, Mark DEANDRADE, Robert PLASSCHAERT, Nico Peter (Niek) VAN TIL